clinical trial · NCT05697861
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Transthyretin-Related (ATTR) Familial Amyloid PolyneuropathyTransthyretin-Related (ATTR) Familial Amyloid CardiomyopathyWild-Type Transthyretin Cardiac Amyloidosis
brief summary
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
started
Jul 10, 2023
primary completion
Mar 1, 2038
completion
Mar 1, 2038
last updated
Aug 26, 2025
official title
Long-Term Follow-Up of Subjects Treated With NTLA-2001
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol